Objective:

To explore the need for continuous manufacturing in cell therapy to meet increasing demand.

Approach:

• Continuous Manufacturing Development: Researchers are developing a continuous manufacturing approach using lipopeptide coatings that allow cells to self-detach, enabling ongoing production without the need for chemical detachment.

Key Findings:

• Current batch processing methods are insufficient to meet the expected demand for cell therapies, as highlighted by Che Connon.
• The continuous approach can support production for one month without a reduction in cell production rate, according to Connon's research.
• Cell yield is around one percent per hour, with the potential for unlimited production based on surface area, as stated by Connon.

Interpretation:

Limitations:

• The rate of cell production is limited by the surface area used.

Conclusion:

Sources:

• Che Connon, Professor of Tissue Engineering